Peter McCallum Cancer Institute

Site:	Peter McCallum Cancer Institute
Address:	10 St Andrews Place
City:	East Melbourne
State:	Victoria
Zip:	3002
Country:	Australia

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib	Terminated	Closed	IPI-504	NCT00688766
3	Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate	Terminated	Closed	Imatinib	NCT00956072
2	A Study of R1507 in Patients With Recurrent or Refractory Sarcoma	Does not allow GIST	Closed	R1507	NCT00642941
2	REGISTER: A multicentre phase 2 study of risk evaluation in GIST with selective therapy escalation for response	Completed	Closed	Imatinib, Nilotinib